Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade and Gemzar in Relapsed or Refractory Aggressive B- and T-cell NHL
NCT00290706Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Apr 2006
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in non-Hodgkin lymphoma (NHL), sponsored by Northwestern University. Started Apr 2006; status: terminated.
02
Drugs
bortezomib
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00290706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290706.